Chargement en cours...
Outcome measures in amyotrophic lateral sclerosis clinical trials
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an average survival of 3–5 years. While therapies for ALS remain limited, basic and translational ALS research has been host to numerous influential discoveries in recent years. These discoveries have led to a large pipeline of...
Enregistré dans:
| Publié dans: | Clin Investig (Lond) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305182/ https://ncbi.nlm.nih.gov/pubmed/28203356 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|